CRPC w/ Bone Metastases
Identification of Key Gene Signatures Associated With Bone Metastasis in Castration-Resistant Prostate Cancer Using Co-Expression Analysis.
February 22, 2021
68Ga-PSMA-11 PET/CT Follow-Up of Patients with Prostate Cancer with Bone Metastases Who Had Reduced Bone Density after Androgen Deprivation Therapy.
February 19, 2021
Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer.
February 5, 2021
Whole-body MRI-based multivariate prediction model in the assessment of bone metastasis in prostate cancer.
February 3, 2021
Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers.
January 19, 2021
Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.
December 29, 2020
Bone Infarction Mimicking a Bone Metastasis on 18F-Prostate-Specific Membrane Antigen PET/CT.
December 22, 2020
Management of cancer pain with analgetic adjuvant and weak opioid in prostate cancer bone metastases: A case series.
December 14, 2020
Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow.
December 11, 2020
Mechanobiological evaluation of prostate cancer metastasis to bone using an in vitro prostate cancer testbed.
December 10, 2020
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
December 7, 2020
The Role of Theranostics in Prostate Cancer.
December 2, 2020
Radium-223 therapy for metastatic castration-resistant prostate cancer: survival benefit when used earlier in the treatment pathway.
December 2, 2020
Radiopharmaceuticals for Bone Metastases.
December 1, 2020